Journal of Gastrointestinal & Digestive System
Open Access

Abstract

Prostate cancer was initially evaluated primarily by T1 and T2 weighted imaging, but recently multiparametric imaging has been introduced. This includes diffusion-weighted imaging and dynamic contrast enhanced imaging. Spectroscopy can also be used in the research setting. Among commonly clinically utilized methods, diffusion-weighted imaging has advantages of short acquisition times, no need for intravenous administration of contrast medium, and the ability to study diffusion of water molecules that indirectly reflects tissue cellularity. Meta-analysis was performed including >5800 lesions and was evaluated using Bayesian receiver operating characteristics. It suggests that DWI improves diagnostic performance and can be a useful adjunct to conventional imaging for identifying prostate cancer within the prostate gland. Example images of prostate cancer and its staging will be demonstrated.

Biography

Vikas Kundra is a Professor of Radiology, Director of Molecular Imaging and has a joint Appointment in the Department of Cancer Systems Imaging at U.T.-MD Anderson Cancer Center. He was trained at Harvard Medical School and Brigham and Women?s Hospital. He has multiple publications in basic, translation, and clinical research and is grant funded. He is a fellow of the Society of Body Computed Tomography and Magnetic Resonance (SCBT-MR). He specializes in body imaging, focused on cancer imaging.